| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |